Phase I study of escalating doses of carfilzomib with HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia.
Brian A JonasSamantha C FischAaron S RosenbergRasmus T HoegJoseph M TuscanoMehrdad AbediPublished in: American journal of hematology (2021)